2/16/2024 0 Comments Vmd stock nyse![]() Louisiana-based Viemed Healthcare (NASDAQ: VMD) provides in-home medical equipment, including respiratory disease management, home sleep testing, sleep apnea treatment, oxygen therapy services, and more. It has an “A” rating in the Portfolio Grader. Earnings for the third quarter included revenue of $4.83 million, which was an increase of 17.8% from a year ago.ĪMS stock trades on the NYSE American exchange, which is for small-cap companies. The stock has been on a roll as of late, rising 30% in the last six months. It partners with some of the best-known facilities in the world, including Johns Hopkins Medical Center in Baltimore, Yale-New Haven Hospital in Connecticut and Tufts Medical Center in Boston. Its products include equipment for radiosurgery, proton beam radiation therapy, intensity-modulated radiation therapy (IMRT) and image-guided IMRT. ![]() Full-year revenue is expected to come in a range of $153 million to $154 million, which would be an increase of 90% from 2021.ĪDMA stock has an “A” rating in the Portfolio Grader.īased in San Francisco, American Shared Hospital Services (NYSEAMERICAN: AMS) leases medical equipment to hospitals and medical centers in the U.S. The company announced that it expects Q4 earnings to be in the range of $49 million to $50 million, which would be a jump of 89% from a year ago. (NASDAQ: NTRS) also increased their holdings of ADMA last year. Hedge funds AWM Investment Company, Blackrock (NYSE: BLK), State Street Corp. Overall, Barclays has a $1.1 million interest in ADMA, which is significant for a company with a market cap of less than $800 million. Barclays recently increased its bet on ADMA stock, increasing the percentage of shares it owns by 316% by buying another 356,000 shares. The stock has been on a tear in recent months, up 86% since August 2022. It manufactures treatments for people who are either naturally or medically immunocompromised for certain infections. Source: Corona Borealis Studio / ShutterstockĪDMA Biologics (NASDAQ: ADMA) is known for its plasma-derived treatments for patients who suffer from compromised immune systems. It’s guided for full-year 2022 revenue to be between $2.58 billion to $2.60 billion, and increase in 2023 to a range of $2.79 billion to $2.86 billion.ĪCHC stock has an “A” rating in the Portfolio Grader. Acadia regularly beats analysts’ estimates for earnings and revenue. CFO David Duckworth says the company has identified 100 metro areas as potential expansion locations because they don’t have enough behavioral health beds. According to the New York Times, staff vacancies in public mental health clinics can run as high as 30%.Īcadia company recently laid out a five-year plan that will prioritize joint ventures in an effort to double revenue. But there’s a gap in services because often insurance doesn’t cover such care, or Medicaid reimbursements don’t fully cover the cost of treatment. The Centers for Disease Control and Prevention estimates that one in 25 adults in the U.S. It’s the largest stand-alone behavioral healthcare company in the U.S. Its facilities help people with behavioral problems, post-traumatic stress disorder, eating disorders and substance abuse. Snapping up or adding to your positions in these healthcare stocks could be just what the doctor ordered – if you are hoping to get a little richer, that is.īased in Tennessee, Acadia Healthcare (NASDAQ: ACHC) operates facilities in 39 states and Puerto Rico, with more than 10,800 beds in 246 locations. My Portfolio Grader tool evaluated healthcare stocks and identified several with “A” grades based on their recent performance, momentum, analyst sentiment and quantitative factors. That’s why the time is now to capitalize on this trend. We’ll be needing and using more drugs as we get older, will rely more on medical professionals and spend more of our incomes on healthcare. ![]() With an aging population comes more medical issues – either ailments that weaken the bodies or medications and treatments to hold off the aging process as long as possible. The World Health Organization says that by 2030, 1 in 6 people on Earth will be at least 60 years old. If you’re not investing in healthcare stocks these days, you may be missing out on a huge opportunity.Ĭonsider this: We are getting older and living longer as a species. InvestorPlace - Stock Market News, Stock Advice & Trading Tips
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |